2m 2m 2m 2m 2m 2m 2m
ARS Pharma (SPRY)
NASDAQ
$5.08-$0.05 (-1.07%)
Price as of Aug 03, 2026 7:35 AM EDT- $509.4MMarket Cap
- -70.14%1-Year Change
- BiotechnologyIndustry
ARS Pharma (SPRY)
$5.08-$0.05 (-1.07%)
SPRY | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.13 | ||
Change | -$0.50 (-8.88%) | ||
Open | $5.55 | ||
High | $5.61 | ||
Low | $5.11 | ||
Previous Close | $5.63 | ||
Volume | 2,083,381 | ||
30-Day Average Volume | 2,217,378 | ||
1-Week Change | -13.64% | ||
1-Month Change | -35.96% | ||
1-Year Change | -70.14% | ||
3-Year Change | -30.20% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 99.3M | ||
Total Assets | $287.6M | ||
Market Cap | $509.4M | ||
Enterprise Value | $581.6M | ||
Period: QTR TTM FY | |||
Revenue | $17.5M | ||
Net Income | -$60.6M | ||
Free Cash Flow | -$44.9M | ||
EBIT | -$60.6M | ||
EBITDA | -$60.2M | ||
Net Working Capital | $195.6M | ||
EPS | -$0.61 | ||
Enterprise Value/EBITDA | -10 | ||
Enterprise Value/Revenue | 33 | ||
P/B | 8 | ||
P/E | -8 | ||
PEG | 0 | ||
Price/Free Cash Flow | -11 | ||
Price/Operating Cash Flow | -11 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue